Decoy Therapeutics Inc. Current Liabilities
Decoy Therapeutics Inc. (DCOY) had Current Liabilities of $4.68 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $4.68M.
- 2026-03-31: Liabilities, Current $4.55M.
- 2025-12-31: Liabilities, Current $5.17M.
- 2024-12-31: Liabilities, Current $1.51M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $4.68M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $4.55M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $5.17M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $1.51M 10-K · filed 2026-03-31 |
| 2019-06-30 | $1.04M 10-Q · filed 2019-07-17 |
| 2019-03-31 | $911.12K 10-Q · filed 2019-05-01 |
| 2018-12-31 | $1.11M 10-Q · filed 2019-07-17 |
| 2018-09-30 | $2.89M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $3.79M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $4.12M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $5.85M 10-K · filed 2019-03-06 |
| 2017-09-30 | $4.97M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $5.03M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $3.22M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $3.89M 10-K · filed 2018-03-07 |
| 2016-09-30 | $3.91M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $3.40M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $3.04M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $2.85M 10-K · filed 2017-03-08 |
| 2015-09-30 | $2.32M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $2.11M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $1.42M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $1.07M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |